Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12133914
Hydrocortisone oral liquid formulations
granted -
US 12134610
Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof
granted -
US 12134642
Antibodies binding to α7β1 integrin antibodies and compositions thereof
granted -
US 12133840
Halogenated xanthene composition and method for treating hematologic cancers
granted -
US 12134631
Hydrophilic linkers for antibody drug conjugates
granted -
US 12134648
Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
granted -
US 12134650
Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
granted -
US 12133890
Antigen-binding polypeptide targeting B7H3 and application thereof
granted -
US 12133853
Pyruvate kinase activators for use in treating blood disorders
granted -
US 12133831
Kits for preparing and delivering purified corticotropin
granted -
US 12133924
Compositions and methods for organ specific delivery of nucleic acids
granted -
WO 2024223388
COMPLEXES CRISTALLINS ENTRE LA VELAGLIFLOZINE ET DES AGENTS DE FORMATION DE CO-CRISTAUX SÉLECTIONNÉS, LEURS PROCÉDÉS DE PRÉPARATION ET LEUR UTILISATION POUR LA PRÉPARATION DE MÉDICAMENTS
granted -
US 12129469
Modified short interfering nucleic acid (siNA) molecules and uses thereof
granted -
US 12129262
CDK inhibitors and their use as pharmaceuticals
granted -
US 12128090
Methods of prophylactic treatment using recombinant VWF (rVWF)
granted -
US 12128015
APE/REF1 inhibitors for the treatment of cancer
granted -
US 12128036
Compositions and methods for storage stable ophthalmic drugs
granted -
US 12128058
Multi-substituent psilocybin derivatives and methods of using
granted -
US 12129471
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
granted -
US 12129476
Methods for measuring the potency of AADC viral vectors
granted -
US 12129467
Non-liposomal systems for nucleic acid delivery
granted -
US 12129258
Diaryl macrocyclic compound and pharmaceutical composition, and use thereof
granted -
US 12129288
Polynucleotides heterodimers of soluble interferon receptors and uses thereof
granted -
US 12128013
Toxic aldehyde related diseases and treatment
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.